Blue Water Biotech, Inc. (Nasdaq: BWV) has signed an Asset Purchase Agreement with WraSer, LLC and Xspire Pharma, LLC for the acquisition of six FDA-approved assets in various medical fields, including cardiology, otic infections, and pain management. 

The purchase will be made for a total cash consideration of $8.5 million, paid in three tranches. 

With this acquisition, Blue Water aims to strengthen its portfolio, enhance its financial position, and expand its capabilities as it transitions into a commercial-stage company. 

The market has responded positively to the announcement, with $BWV trading at $1.85, reflecting a significant increase of $1.06 (+134.17%) in pre-market.

Plug Power Inc. (Nasdaq: PLUG) is hosting Analyst Day today at its Gigafactory in Rochester, NY. 

The management team will present revenue growth opportunities in the Applications and Energy business units and provide a financial update. They will also showcase the operational scale of Plug's manufacturing facilities, emphasizing the company's ability to deliver innovative and sustainable hydrogen solutions.

Plug's ambitions for 2030 include producing over 2,000 tons of hydrogen per day, deploying one gigawatt of stationary power products, and delivering 500,000 fuel cell-powered forklift trucks. The company is positioning itself to support 10 GW of fuel cells and electrolyzers and aims to have 100,000 HyVia vans on the road through its partnership with Renault. 

Additionally, Plug introduced the HL 1500, the market’s first portable hydrogen refueler designed to reduce infrastructure costs and deployment time for hydrogen-powered commercial vehicles. The HL 1500 has garnered immediate demand from major transit agencies and offers a cost-effective solution for fleet fueling. Accordging to the company, three transit customers will receive the first shipments by the end of this year

$PLUG is currently trading at $12.02 in pre-market, up $1.11 (+10.17%) 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)